Global PARP Inhibitor Market is estimated to be US$ 41435.5 million by 2030 with a CAGR of 34.3% dur

Siju Thomas13 Jun, 2022News

The report " Global PARP Inhibitor Market, By Drug (Lynparza, Niraparib, Rucaparib and Others), By Indication (Ovarian cancer, Breast cancer, Prostate cancer, Lung cancer and Others), By Distribution Channel (Hospital pharmacies, Online pharmacies and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030?